Concepedia

Marco Guadagnoli

MG

6

Publications

398

Citations

6

H-Index

2008

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Amsterdam UMC Location University of Amsterdam

Institut de Génétique Moléculaire de Montpellier

Marco Guadagnoli is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pathology, and immunoassays.

Top concepts

Publications per year

2008–2023

6

Publications

6

The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice

Neri Mercatelli, Valeria Coppola, Désirée Bonci et al. · PLoS ONE · 2008 · 250 citations · Full text

Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas

Marco Guadagnoli, Fiona C. Kimberley, Uyen Phan et al. · Blood · 2011 · 54 citations

Epitope mapping of monoclonal antibodies: a comprehensive comparison of different technologies

Xibei Dang, Lars Guelen, D. Lutje Hulsik et al. · mAbs · 2023 · 27 citations · Full text

, , +25

The TNF family member APRIL promotes colorectal tumorigenesis

Valeria Lascano, L F Zabalegui, Kate Cameron et al. · Cell Death and Differentiation · 2012 · 26 citations · Full text

, , +4

Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model

Valeria Lascano, Marco Guadagnoli, Jan G. Schot et al. · Blood · 2013 · 25 citations · Full text

Rows per page

1–5 of 6